Cancer Survivors Club 📙

I share evidence-based cancer news, research breakthroughs and survivor stories — no hype, no miracle cures. This feed is for patients, families, clinicians and anyone who believes progress matters. Follow for facts, hope & real science! Curated by @Chris_Geiger #TCSC

Volunteers drive cancer patients to treatment. They greet families at Hope Lodge with kindness that softens the fear. That quiet, invisible work saves lives. Thank you. cancer.org/support-progra… #CancerCare #Volunteers #TCSC

Sarcoma; 175+ different tumor types, affecting 1% of cancer patients. Molecular testing every patient is how we find targets we’d otherwise miss. Precision medicine is arriving for one of oncology’s most neglected cancers. cancernetwork.com/view/advancing… #Sarcoma #RareCancers #TCSC

Pancreatic cancer: deadliest major cancer. 5-year survival stuck at 13% for 3 years running. Today @PanCAN launches a $250M campaign to change that. pancan.org/news/announcin… #PancreaticCancer #WageHope #TCSC

Tumors build walls to block the immune system’s natural killer cells. McGill researchers found how to tear those walls down; without permanently altering cells. Works on leukemia, brain, kidney & triple-negative breast cancer. news-medical.net/news/20260424/… #CancerResearch #TCSC

Small cell lung cancer finally has new weapons. T-cell engagers & ADCs are delivering survival gains once thought impossible in one of oncology’s hardest diseases. curetoday.com/view/what-new-… #SCLC #LungCancer #TCSC

CAR-T therapy works; but it takes weeks & costs hundreds of thousands. Duke researchers just found a way to engineer those cancer-fighting cells directly inside the body. Game changer for access. today.duke.edu/2026/04/new-wa… #CART #CancerResearch #TCSC

Targeted therapies can kill 98-99% of lung cancer cells; but that last 1-2% adapts, resists, and comes back. Researchers at CU Anschutz are studying whether CAR T cells can finish the job by attacking those surviving cells. news.cuanschutz.edu/cancer-center/… #LungCancer #CART #TKI #TCSC

Dr. Kevin Kim, newly appointed chief of precision medicine at Sutter Health, is applying decades of cancer research expertise to personalize treatment for patients from diagnosis through survivorship. vitals.sutterhealth.org/sutter-health-… #CancerCare #Oncology #PatientCare #TCSC

A landmark study from Fred Hutch, published in Nature Biotechnology, has expanded the number of usable FDA-approved kinase drugs from 89 to 235; meaning dozens of existing cancer drugs may work on more cancers than thought! fredhutch.org/en/news/center… #CancerResearch #Oncology #TCSC

A moment of pure resilience: 26-year-old Sydney Towle shares how she found joy again during a break from cancer treatment, reminding us survival is also about living fully. people.com/sydney-towle-s… #CancerSurvivor #Hope #Inspiration #TCSC

Targeted lung cancer therapies can kill 98-99% of tumour cells; but that surviving 1-2% adapts and comes back. CU Anschutz researchers are investigating how CAR T therapy can mop up resistant cells! news.cuanschutz.edu/cancer-center/… #LungCancer #CART #TKI #CancerResearch #TCSC

Here is an unexpected finding worth knowing: cancer patients who received an mRNA COVID-19 vaccine within 100 days of starting immune checkpoint therapy were twice as likely to survive three years after treatment. cityofhope.org/hope-matters-b… #COVID19 #mRNA #CheckpointInhibitors #TCSC

A new phase 2 study from NYU Langone found that adding pembrolizumab to standard treatment allowed 60% of muscle-invasive bladder cancer patients to keep their bladder for up to two years. nyulangone.org/news/immunothe… #BladderCancer #Immunotherapy #CancerTreatment #OncologyNews #TCSC

Researchers at UBC have developed a targeted antibody-drug conjugate that precisely destroys tumour cells in Ewing sarcoma, lymphoma & other aggressive cancers; yet leaving healthy tissue untouched. med.ubc.ca/news/new-targe… #ChildhoodCancer #Cancer #OncologyInnovation #TCSC

More than 70% of cancers , including breast, bladder & cervical; carry mutations linked to a family of enzymes called APOBEC. A $10 million NCI-funded program is working to shut those enzymes down before! news.uthscsa.edu/ut-san-antonio… #APOBEC #PrecisionOncology #CancerTreatment #TCSC

Lung cancer kills more Americans than any other cancer, yet it remains one of the most stigmatized and underfunded. Sue is working to change that. So can we. #LungCancerAwareness #EndTheStigma #TCSC

Sue was training for a half marathon when a dry cough she couldn’t shake led to a Stage 3C lung cancer diagnosis. Now she advocates so others don’t feel as lost and overwhelmed as she once did. lung.org/blog/cancer-ad… #LungCancer #LungForce #CancerAdvocacy #PatientStories #TCSC

One of the cruelest things pancreatic cancer does is develop resistance to chemo. A new antibody called NP137, published today in Nature, may stop it from happening and add months of life. nature.com/articles/s4158… #PancreaticCancer #Chemotherapy #CancerResearch #NP137 #TCSC

For decades, the genetic mutation driving nearly 90% of pancreatic cancers was considered impossible to target with drugs. Researchers are closing in on a treatment that may change everything. nationalgeographic.com/health/article… #KRAS #PancreaticCancer #CancerBreakthrough #OncologyNews #TCSC

Pancreatic cancer has resisted treatment advances for decades. Now, new clinical trial data is giving patients and families real reasons to hope. The science is finally catching up. washingtonpost.com/health/2026/04… #PancreaticCancer #CancerResearch #ClinicalTrials #Oncology #TCSC